MALDI-TOF MS Combined With Magnetic Beads for Detecting Serum Protein Biomarkers and Establishment of Boosting Decision Tree Model for Diagnosis of Hepatocellular Carcinoma

Taizhou Municipal Hospital, Taizhou University, Taizhou, Zhejiang, China.
American Journal of Clinical Pathology (Impact Factor: 2.51). 08/2010; 134(2):235-41. DOI: 10.1309/AJCPA6C6NOGFLYIR
Source: PubMed


No single biologic marker is used in the routine diagnosis of hepatocellular carcinoma (HCC). We screened for potential biomarkers in 142 samples, including samples from 60 patients with HCC, 36 patients with hepatic disease other than HCC, and 46 age- and sex-matched healthy volunteers. Pretreated samples were analyzed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) combined with weak cationic exchange magnetic beads. The diagnostic pattern with a panel of 4 potential protein biomarkers of a mass-to-charge (m/z) ratio of 4,471, 8,936, 11,670, and 13,752 could accurately recognize 56 of 60 patients with HCC, 34 of 36 patients with hepatic disease, and 44 of 46 healthy people. The preliminary data suggest a potential application of MALDI-TOF MS combined with magnetic beads as an effective technology to profile serum proteome, and, with pattern analysis, a diagnostic model comprising 4 potential biomarkers was indicated to differentiate people with hepatic disease and healthy control subjects rapidly and precisely.

6 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: To screen for the potential protein biomarkers in serum for the diagnosis of lung adenocarcinoma using proteomic fingerprint technology. Methods: Proteomic fingerprint technology combining magnetic beads (SED) with Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) was used to profile and compare the serum proteins from 138 patients with lung adenocarcinoma and 120 healthy blood donors. Results: A total of 38 discriminating m/z peaks were identified that were related to lung adenocarcinoma (P<0.01). Four differently expressed potential biomarkers were identified with the relative molecular weights of 11644.1Da, 6298.7Da, 5840.4Da, and 3975.2Da, respectively. Among them 2 proteins with m/z 6298.7Da, 3975.2Da decreased, and 2 proteins with m/z 5840.4Da, 11644.1Da increased in lung adenocarcinoma. This diagnostic model can distinguish lung adenocarcinoma from healthy controls with a sensitivity of 92.85% and a specificity of 91.25%. Conclusions: Biomarkers for lung adenocarcinoma could be discovered in serum by MALDI-TOF-MS combining the use of SED.
    Preview · Article · May 2011 · Laboratory Medicine
  • [Show abstract] [Hide abstract]
    ABSTRACT: The objective of this study was to search for potential protein biomarkers in serum for diagnosis of ovarian cancer, by use of proteomic fingerprint techniques. MALDI-TOF-MS was combined with magnetic beads to profile and compare serum protein spectra from 40 ovarian cancer patients and from 60 healthy controls. The tree analysis model of potential cancer biomarkers was constructed with Biomarker Patterns software on the basis of three identified biomarkers (5486, 6440, and 13720 Da), resulting in excellent discrimination between the ovarian cancer and non-cancer in our tests. The sensitivity was 90% and the specificity was 86.7%. In a blind test the sensitivity was 88% and the specificity was 83.3%. The results suggested that biomarkers for ovarian cancer diagnosis in serum could be identified by MALDI-TOF-MS combined with the use of magnetic beads. The use of combined biomarkers would further enable powerful and reliable diagnosis of ovarian cancer with high sensitivity and specificity.
    No preview · Article · Jun 2011 · International Journal of Clinical Oncology
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Proteomic techniques are promising strategies in the surveillance of hepatocellular carcinoma (HCC). This study aimed to investigate the serum profiling with magnetic bead (MB) and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) and to further identify the biomarkers for HCC. Serum samples from 80 chronic hepatitis B (CHB) patients, 94 HCC concomitant with HBV patients and 24 healthy subjects were examined by MALDI-TOF MS after peptide enrichment on MBs. Based on the genetic algorithm, diagnostic models for HCC were established between 30 HCC patients and 24 healthy subjects/30 CHB patients. Validations were done with the remaining cases. Markers in the models were identified through liquid chromatography (LC)/MS–MS. The three groups were well separated from each other and two discrimination models were established for HCC. The overall recognition capability of these two models was 96.25% and 93.33%, respectively. Validations showed the misdiagnosis ratio for HCC was 1.6% and 23.4%, respectively. The identified biomarkers for HCC included prothrombin precursor (fragment), calcium-dependent secretion activator 1, Baculoviral inhibitor of apoptosis repeat-containing protein 6, etc. MB-based MALDI-TOF MS is applicable in identifying the serum biomarkers and can be used in the surveillance of HCC among HBV-infected patients.
    Preview · Article · Jun 2011 · Acta Biochimica et Biophysica Sinica
Show more